DK0434394T3 - Forbindelser til behandling af inflammatorisk tarmsygdom - Google Patents

Forbindelser til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK0434394T3
DK0434394T3 DK90313923T DK90313923T DK0434394T3 DK 0434394 T3 DK0434394 T3 DK 0434394T3 DK 90313923 T DK90313923 T DK 90313923T DK 90313923 T DK90313923 T DK 90313923T DK 0434394 T3 DK0434394 T3 DK 0434394T3
Authority
DK
Denmark
Prior art keywords
inflammatory bowel
bowel disease
compounds
treatment
benzyl
Prior art date
Application number
DK90313923T
Other languages
Danish (da)
English (en)
Inventor
Jaswant Singh Gidda
Jill Ann Panetta
Michael Leroy Phillips
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0434394T3 publication Critical patent/DK0434394T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Surgical Instruments (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90313923T 1989-12-21 1990-12-19 Forbindelser til behandling af inflammatorisk tarmsygdom DK0434394T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
DK0434394T3 true DK0434394T3 (da) 1998-12-14

Family

ID=23803709

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90313923T DK0434394T3 (da) 1989-12-21 1990-12-19 Forbindelser til behandling af inflammatorisk tarmsygdom

Country Status (22)

Country Link
EP (1) EP0434394B1 (de)
JP (1) JP3036853B2 (de)
KR (1) KR0176243B1 (de)
CN (1) CN1029846C (de)
AT (1) ATE169294T1 (de)
AU (1) AU639734B2 (de)
CA (1) CA2032330C (de)
CY (1) CY2100B1 (de)
DE (1) DE69032537T2 (de)
DK (1) DK0434394T3 (de)
ES (1) ES2121748T3 (de)
FI (2) FI104251B1 (de)
HU (1) HU216732B (de)
IE (1) IE904633A1 (de)
IL (3) IL108962A (de)
MX (1) MX23803A (de)
NO (1) NO300458B1 (de)
NZ (1) NZ236472A (de)
PT (1) PT96198B (de)
RU (2) RU2036915C1 (de)
YU (1) YU240690A (de)
ZA (1) ZA9010041B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
EP0915090A1 (de) * 1992-09-10 1999-05-12 Eli Lilly And Company Thiazolidinone Derivate als hypoglykämisches Mittel und für die Behandlung der Alzheimer Krankheit
EP0595546B1 (de) * 1992-10-28 1996-03-20 Shionogi & Co., Ltd. Benzylidenderivate
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
ES2146837T3 (es) * 1995-09-07 2000-08-16 Lilly Co Eli Procedimiento para preparar derivados de la rodanina sustituidos con bencilo.
ES2153081T3 (es) * 1995-09-07 2001-02-16 Lilly Co Eli Forma cristalina alternativa de tazofelona((+,-)-5-((3,5-bis(1,1-dimetiletil)-4-hidroxifenil)metil)-4-tiazolidinona).
EP0779282A1 (de) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinon-Verbindungen zur Behandlung von Multiple-Sklerose
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US6005142A (en) 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
AU6331099A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
WO2000018747A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
WO2000018748A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
PL376147A1 (en) * 2002-09-30 2005-12-27 The Regents Of The University Of California Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
WO2011128018A1 (en) * 2010-04-15 2011-10-20 Merck Patent Gmbh Process for the preparation of hydroquinones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL79648A (en) * 1985-08-09 1991-12-12 Lilly Co Eli Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
DK0391644T3 (da) * 1989-04-07 1996-07-15 Lilly Co Eli Arylsubstituerede rhodaninderivater

Also Published As

Publication number Publication date
IE904633A1 (en) 1991-07-17
DE69032537T2 (de) 1999-01-21
HU908368D0 (en) 1991-07-29
ZA9010041B (en) 1992-08-26
AU6826690A (en) 1991-06-27
FI906273A (fi) 1991-06-22
JP3036853B2 (ja) 2000-04-24
YU240690A (sh) 1992-12-21
NO300458B1 (no) 1997-06-02
KR0176243B1 (ko) 1999-03-20
FI19991698A (fi) 1999-08-10
ES2121748T3 (es) 1998-12-16
EP0434394A2 (de) 1991-06-26
RU2050355C1 (ru) 1995-12-20
FI906273A0 (fi) 1990-12-19
EP0434394A3 (en) 1992-01-08
ATE169294T1 (de) 1998-08-15
RU2036915C1 (ru) 1995-06-09
NZ236472A (en) 1993-03-26
JPH04279573A (ja) 1992-10-05
FI104251B (fi) 1999-12-15
CN1029846C (zh) 1995-09-27
CA2032330C (en) 2001-05-08
PT96198A (pt) 1991-09-30
AU639734B2 (en) 1993-08-05
DE69032537D1 (de) 1998-09-10
MX23803A (es) 1994-02-28
FI104251B1 (fi) 1999-12-15
HUT59915A (en) 1992-07-28
CY2100B1 (en) 2002-04-05
CN1052668A (zh) 1991-07-03
CA2032330A1 (en) 1991-06-22
IL108962A0 (en) 1994-06-24
KR910011812A (ko) 1991-08-07
IL108962A (en) 1996-12-05
IL96654A (en) 1995-06-29
HU216732B (hu) 1999-08-30
PT96198B (pt) 1998-05-29
NO905478L (no) 1991-06-24
NO905478D0 (no) 1990-12-19
EP0434394B1 (de) 1998-08-05

Similar Documents

Publication Publication Date Title
DK0434394T3 (da) Forbindelser til behandling af inflammatorisk tarmsygdom
IS4638A (is) Aðferð við ljósfræðilega hreinsun á bensimidasólafleiðum með hækkað hlutfall enantíómera
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
AT383130B (de) Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
DE3676922D1 (de) Neue polyoxygenierte labdan-derivate, verfahren zu ihrer herstellung und ihre anwendung als medikamente.
PT97547A (pt) Processo para a preparacao de novas pirido {2,3-f}{1,4}tiazepinas e pirido {3,2-b}{1,5}benzotiazepinas e de composicoes farmaceuticas que as contem
DE3481510D1 (de) Optisch aktive verbindungen mit antitassiver und zentral-sedativer wirkung, ein verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
ATE65779T1 (de) Verfahren zur herstellung von carbinolderivaten.
DE69527802D1 (de) Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten
DK0431305T3 (da) Fremgangsmåde til fremstilling af molluskicide 2,4,5-tribrompyrrol-3-carbonitriler
CS53688A2 (en) Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production
FR2647959B1 (fr) Procede de fabrication simultanee de transistors mos a canal n et de transistors bipolaires verticaux pnp
NO950952L (no) Fremgangsmåte for fremstilling av pilokarpin
DE3864286D1 (de) Herstellungsverfahren von trifluormethylverbindungen.
NO980937L (no) Fremgangsmåte for fremstilling av benzyl-substituerte rhodaninderivater
HU9203625D0 (en) Stereoselective process for producing optical isomers of 1-benzoyl-4-hydroxi-5-(1-phenyl-ethyl)-amino-1,2,2a,3,4,5-hexahydrobenz/cd/-indole